By successfully completing the acquisition of life sciences distributor Bosung in Korea and medical devices distributor MedWorkz in Singapore, DKSH continues to drive market consolidation and expands its leading positions in Asia Pacific.
Media release
Zurich, Switzerland, April 1, 2021 ‒ In Business Unit Technology, DKSH has successfully completed the acquisition of Bosung in Korea to further solidify DKSH's position as a leading Pan-Asian provider of scientific instrumentation. In Business Unit Healthcare, DKSH has closed the acquisition of MedWorkz to expand its medical device business in Singapore and to drive into higher value segments and services.
Stefan P. Butz, CEO of DKSH, said: "We are pleased that – with Bosung and MedWorkz – we have already closed two transactions this year. Life sciences and medical devices are key expansion areas for us, and the product portfolios of the acquired businesses ideally complement our services. I welcome all new Bosung and MedWorkz colleagues and look forward to a successful collaboration.”
For further information, please contact:
DKSH Holding Ltd.
Till Leisner
Head, Group Investor & Media Relations
Phone +41 44 386 7315
till.leisner@dksh.com
Demet Biçer
Manager, Group Media Relations
Phone +41 44 386 7217
demet.bicer@dksh.com
DKSH Business Unit Technology
Irene Chen
Director, Group Marketing
Phone +886 2 8752 7611
irene.yr.chen@dksh.com
About DKSH
At DKSH, our purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. www.dksh.com